The Allogeneic Future with Poseida's Kristin Yarema, Ph.D.
Business Of Biotech
Intro
This chapter explores the innovative strategies of Poseida Therapeutics in developing allogeneic CAR T cell therapies, emphasizing the benefits of donor-derived approaches. The newly appointed CEO shares insights on the company's partnerships and clinical programs aimed at improving treatment options for hematologic and solid tumors.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
